Sanofi (SNY) Inventory Average (2018)

Sanofi (SNY) posted Inventory Average of $4.3 billion for Q4 2018, up 2723.43% sequentially from $153.8 million in Q3 2018.

Sanofi (SNY) Inventory Average (2018) Analysis & Trends

Sanofi has reported Inventory Average for 1 years, with the latest figure at $4.3 billion in Q4 2018.

Quarterly Inventory Average changed N/A year-over-year to $4.3 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $4.3 billion (changed N/A YoY) and the FY2025 annual result came in at $11.0 billion, up 6.98% from the prior year.
Inventory Average climbed to $4.3 billion in Q4 2018 per SNY's latest filing, from $153.8 million in the prior quarter.
Over five years, Inventory Average peaked at $8.3 billion in Q1 2018 and troughed at $153.8 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Johnson & Johnson	645.88 Bn	625.12 Bn	17.26 Bn	14.86 Bn
2	AbbVie	463.46 Bn	456.89 Bn	12.70 Bn	5.09 Bn
3	Merck	367.92 Bn	360.78 Bn	12.21 Bn	6.34 Bn
4	Novartis Ag	297.71 Bn	290.02 Bn	11.24 Bn	-
5	Astrazeneca	255.55 Bn	250.65 Bn	12.86 Bn	6.75 Bn
6	Amgen	234.52 Bn	220.53 Bn	7.24 Bn	6.20 Bn
7	Gilead Sciences	178.22 Bn	175.04 Bn	6.22 Bn	1.93 Bn
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn	10.31 Bn
9	Gsk	105.32 Bn	101.15 Bn	8.24 Bn	8.36 Bn
10	Sanofi	54.20 Bn	46.82 Bn	10.79 Bn	-

Download Data